Published in Women's Health Weekly, October 26th, 1998
This study will evaluate and compare the response of women and men to the protease inhibitor FortovaseTM (saquinavir) in combination with two nucleoside reverse transcriptase inhibitors (NRTIS) in HIV positive patients.
"This study is a critical step forward in better understanding the treatment of HIV/AIDS in women," said Carmen Zorrilla, MD,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.